Ortho-Clinical Diagnostics, Inc. [Raritan / United States of America]
Ortho-Clinical Diagnostics, Inc. [Raritan / United States of America] located in RARITAN NEW JERSEY, United States of America had its last known inspection on 09 Dec 2022. There are 23 known inspections on record.
Site Details
Industries:
Biologics,
Medical Devices,
Human Drugs
Tags:
Biologics,
Biologics Manufacturer,
Medical Devices: In Vitro Diagnostics,
Medical Devices,
Biologics: Vaccines,
Human Drugs,
Analytical Testing,
Manufacturer,
Vaccines,
Biologics: HCT/P,
Medical Device Manufacturer
Last Inspection Date:
09 Dec 2022
FEI:
2250051
Redica ID:
Investigators:
Simone E Pitts,
Jennifer Macmillan,
Helen B Ricalde,
Joanne Pryzbylik,
Sarah Forney,
Ann Marie Montemurro,
LCDR Debra Emerson,
Mariza M Jafary,
Omotunde O Osunsanmi,
Qiao Y Bobo,
Jacqueline Mdiaz Albertini,
Gene D Arcy,
Kimberly M Bigler,
Paula A Trost,
Christian D Lynch (CDL),
Richard D Manney,
Ana S Cabrera,
Burnell M Henry,
Martha T Olone,
Teresita C Mercado,
Prabhu P Raju,
Rose Ashley,
Joan A Loreng,
Creighton T Tuzon,
Ann Marie Schofield,
Byungja E Marciante,
J David Doleski,
Jean M Kelahan,
Marion Michaelis,
Annemarie Bodnar,
Althea A Williams,
Dawn L Wydner,
Kelly I Anderson,
Julie D Bringger,
Sheryl A Kochman,
Mary T Carden,
Meihong Liu
Ortho-Clinical Diagnostics, Inc. [Raritan / United States of America]'s Most Recent Documents
| Publish Date | Document Type | Title |
|---|---|---|
| December, 2022 | FDA 483 | Ortho-Clinical Diagnostics, Inc. - Form 483, 2022-12-09 |
| January, 2005 | EIR | Ortho-Clinical Diagnostics, Inc. - EIR, 2005-01-18 |
| August, 2004 | FDA 483 Response | Ortho-Clinical Diagnostics, Inc. - Form 483R, 2004-08-24 |
| August, 2004 | FDA 483 | Ortho-Clinical Diagnostics, Inc. - Form 483, 2004-08-04 |
| August, 2004 | EIR | Ortho-Clinical Diagnostics, Inc. - EIR, 2004-08-04 |
Experience Redica Systems’ NEW site dashboards and profiles
Redica Systems customers can leverage the full Quality and Regulatory Intelligence suite, with powerful analysis covering thousands of sites around the world. You can search by FEI, or more powerfully, by the Redica ID, our universal identifier for global life sciences manufacturing sites, an industry first.
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Loading...
Site Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to our extensive inventory of site profiles, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more